Article Text

other Versions

Optimal medical therapy after acute myocardial infarction
  1. Peter Bramlage1,
  2. Ulrich Tebbe2
  1. 1Institute for Cardiovascular Pharmacology and Epidemiology, Mahlow, Germany
  2. 2Klinikum Lippe GmbH, Fachbereich Herz-Kreislauf, Detmold, Germany
  1. Correspondence to Professor Dr Ulrich Tebbe, Klinikum Lippe GmbH, Fachbereich Herz-Kreislauf, Röntgenstrasse 18, 32756 Detmold, Germany; ulrich.tebbe{at}

Statistics from

The Authors' reply: Thank you for your kind appreciation of our work.1 We fully agree with the comments you made and would like to take the opportunity to further clarify some important aspects.

(1) Patients who had contraindications to any of the components of optical medical therapy (OMT), such as hypotension for β-blocker use, thrombocytopenia for antiplatelet use, etc, were excluded from this analysis.2 Further 1-year mortality rates were adjusted …

View Full Text

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Linked Articles